Conquis Financial’s Medtronic MDT Stock Holding History

Conquis Financial’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-48	Closed	-$3.83K	–	143
2024 Q4	$3.83K	Buy	+48	New	+$4.16K	﹤0.01%	130

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Conquis Financial's MDT Position: Q1 2025 in Review

Conquis Financial sold out of Medtronic (MDT) in Q1 2025, closing a stake of 48 shares — an estimated $3.83K sold.

Conquis Financial first reported a position in MDT in Q4 2024 and held it in 1 quarter. The position peaked at $3.83K in Q4 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

Conquis Financial reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
Conquis Financial sold 48 Medtronic shares in Q1 2025, an estimated $3.83K.
Conquis Financial first reported a position in Medtronic in Q4 2024 and held it in 1 quarter.
Conquis Financial's Medtronic position peaked at $3.83K in Q4 2024.
2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Conquis Financial's 13F filing for Q1 2025, filed 9 May 2025.